Minimal antibody response in Imbokodo compels change of course for HIV vaccine research
It is 13 years now since RV144 became the only HIV vaccine ever to produce a (marginally) positive result in a large efficacy trial. And it’s eight years since aidsmap.com said that the vaccine’s results were “real – and could be made to work better.” An analysis presented yesterday at the International AIDS Conference of …
Minimal antibody response in Imbokodo compels change of course for HIV vaccine research Read More »